Follow
Bita Sahaf
Bita Sahaf
Research Scientist, PhD
Verified email at stanford.edu
Title
Cited by
Cited by
Year
The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford
LA Herzenberg, D Parks, B Sahaf, O Perez, M Roederer, LA Herzenberg
Clinical chemistry 48 (10), 1819-1827, 2002
8622002
Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing
SD Boyd, EL Marshall, JD Merker, JM Maniar, LN Zhang, B Sahaf, ...
Science translational medicine 1 (12), 12ra23-12ra23, 2009
5732009
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ...
Nature 603 (7903), 934-941, 2022
4062022
Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal
S Salzano, P Checconi, EM Hanschmann, CH Lillig, LD Bowler, P Chan, ...
Proceedings of the National Academy of Sciences 111 (33), 12157-12162, 2014
3752014
Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements
SD Boyd, BA GaŰta, KJ Jackson, AZ Fire, EL Marshall, JD Merker, ...
The Journal of Immunology 184 (12), 6986-6992, 2010
3482010
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
JY Spiegel, S Patel, L Muffly, NM Hossain, J Oak, JH Baird, MJ Frank, ...
Nature medicine 27 (8), 1419-1431, 2021
3332021
Modern flow cytometry: a practical approach
JW Tung, K Heydari, R Tirouvanziam, B Sahaf, DR Parks, LA Herzenberg, ...
Clinics in laboratory medicine 27 (3), 453-468, 2007
2822007
High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment
AC Logan, H Gao, C Wang, B Sahaf, CD Jones, EL Marshall, I Bu˝o, ...
Proceedings of the National Academy of Sciences 108 (52), 21194-21199, 2011
2392011
Thioredoxin reductase, a redox-active selenoprotein, is secreted by normal and neoplastic cells: presence in human plasma
A Söderberg, B Sahaf, A RosÚn
Cancer research 60 (8), 2281-2289, 2000
2262000
Lymphocyte surface thiol levels
B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg
Proceedings of the National Academy of Sciences 100 (7), 4001-4005, 2003
1862003
Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence
S Arai, B Sahaf, B Narasimhan, GL Chen, CD Jones, R Lowsky, ...
Blood, The Journal of the American Society of Hematology 119 (25), 6145-6154, 2012
1182012
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma
JH Baird, DJ Epstein, JS Tamaresis, Z Ehlinger, JY Spiegel, J Craig, ...
Blood advances 5 (1), 143-155, 2021
1072021
Comprehensive immune monitoring of clinical trials to advance human immunotherapy
FJ Hartmann, J Babdor, PF Gherardini, EAD Amir, K Jones, B Sahaf, ...
Cell reports 28 (3), 819-831. e4, 2019
1012019
Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy
Z Good, JY Spiegel, B Sahaf, MB Malipatlolla, ZJ Ehlinger, S Kurra, ...
Nature Medicine 28 (9), 1860-1871, 2022
932022
Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species
B Sahaf, A S÷derberg, G Spyrou, AM Barral, K Pekkari, A Holmgren, ...
Experimental cell research 236 (1), 181-192, 1997
911997
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
CE Ryan, B Sahaf, AC Logan, S O’Brien, JC Byrd, P Hillmen, JR Brown, ...
Blood, The Journal of the American Society of Hematology 128 (25), 2899-2908, 2016
902016
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
S Heitzeneder, KR Bosse, Z Zhu, D Zhelev, RG Majzner, MT Radosevich, ...
Cancer Cell 40 (1), 53-69. e9, 2022
892022
The extracellular microenvironment plays a key role in regulating the redox status of cell surface proteins in HIV-infected subjects
B Sahaf, K Heydari, LA Herzenberg, LA Herzenberg
Archives of Biochemistry and Biophysics 434 (1), 26-32, 2005
822005
Clinical impact of HY alloimmunity
R Popli, B Sahaf, H Nakasone, JYY Lee, DB Miklos
Immunologic research 58, 249-258, 2014
802014
Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans
H Nakasone, L Tian, B Sahaf, T Kawase, K Schoenrock, S Perloff, ...
Blood, The Journal of the American Society of Hematology 125 (20), 3193-3201, 2015
702015
The system can't perform the operation now. Try again later.
Articles 1–20